Icon Plc

NASDAQ: ICLR
$147.04
+$1.38 (+0.9%)
Closing Price on June 16, 2025

ICLR Stock Chart and Intraday Price

ICLR Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector TRADE & SERVICES
Industry SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Address SOUTH COUNTY BUSINESS PARK, LEOPARDSTOWN, DUBLIN 18, IE
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 26,852.98M USD
Shares Outstanding 82,495,000
Icon Plc is a global clinical research organization based in Dublin, Ireland, offering a wide range of services to the pharmaceutical, biotechnology, and medical device industries. The company specializes in managing all stages of the clinical development process, from early compound selection through to Phase I-IV clinical studies. Icon Plc provides comprehensive services including clinical trial management, consulting, laboratory services, and post-market commercialization support. With a focus on innovation, Icon Plc supports its clients in bringing new medicines and treatments to market efficiently and effectively.

ICLR Articles

The relentless bull run led by high-flying growth stocks is no longer here, and 2025 has brought a significant shift in the market landscape, with the S&P 500 now in correction territory. It is...